Last reviewed · How we verify
SCTT11
At a glance
| Generic name | SCTT11 |
|---|---|
| Sponsor | Sinocelltech Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SCTT11 CI brief — competitive landscape report
- SCTT11 updates RSS · CI watch RSS
- Sinocelltech Ltd. portfolio CI